Back to Search
Start Over
BioAtla to Host Virtual R&D Day on Clinical Program and Pipeline Updates on July 25, 2024
- Source :
- GlobeNewswire. June 27, 2024
- Publication Year :
- 2024
-
Abstract
- SAN DIEGO, June 27, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.799138047